Experimental procedures were approved by the Institutional Board of Hospital de La Princesa (PI-802)
These GLP-1 receptor agonists are increasingly prescribed for obesity and weight management, helping many people reduce appetite, regulate blood sugar and lose significant weight over time
Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk
Blood Sugar Regulation : Improves insulin sensitivity and supports healthy blood sugar levels
Help Shape the Future of Diabetes Care by Joining the UCLA Diabetes Research Registry Semaglutide injections for weight loss Currently, semaglutide is only approved for weight loss under the brand name Wegovy
Most insulins, especially the long-acting basal (background) insulins, can burn a bit upon injection if the liquid is cold, like when just removed from a refrigerator